Recruitment

Recruitment Status
Terminated

Exclusion Criterias

severe kidney disease (creatinine clearance < 30 mL min)
life expectancy < 6 months
allergy to contrast media
...
severe kidney disease (creatinine clearance < 30 mL min)
life expectancy < 6 months
allergy to contrast media
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
refusal to provide informed consent or inability to follow up
the lesion cannot be accessed with the wire guide
pregnancy
prior history of ipsilateral DVT or femoral catheters

Summary

Conditions
  • Deep Vein Thrombosis
  • Venous Thromboembolism
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Exclusion Criterias

severe kidney disease (creatinine clearance < 30 mL min)
life expectancy < 6 months
allergy to contrast media
...
severe kidney disease (creatinine clearance < 30 mL min)
life expectancy < 6 months
allergy to contrast media
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
refusal to provide informed consent or inability to follow up
the lesion cannot be accessed with the wire guide
pregnancy
prior history of ipsilateral DVT or femoral catheters

Locations

Ottawa, Ontario, K1H 8L6
Ottawa, Ontario, K1H 8L6

Tracking Information

NCT #
NCT02066597
Collaborators
Not Provided
Investigators
  • Principal Investigator: Esteban Gandara, MD OHRI
  • Esteban Gandara, MD OHRI